3 Highest Growth Stocks in the Market Today
I'm constantly scanning the market for stocks that promise hyper growth in the years ahead. One tool that I use to find these high growth companies is Finviz. With that in mind, I recently ran a screen on Finviz searching for the following attributes:
From there, I simply sorted by projected earnings-growth rate over the coming five years. These criteria identified three stocks -- Freeport-McMoRan (NYSE: FCX), Corcept Therapeutics (NASDAQ: CORT), and Penumbra (NYSE: PEN) -- that all are expected to grow EPS in excess of 67% annually over the next five years.
Let's take a closer look at each to see if any could actually be worth buying.
Source: Fool.com
Corcept Therapeutics Inc. Aktie
32,25 €
1,32 %
Die Corcept Therapeutics Inc. Aktie wird von der Community stark bevorzugt: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein leichtes Potenzial nach oben für Corcept Therapeutics Inc. mit einem Kursziel von 36 € gegenüber dem aktuellen Kurs von 32.25 €.
